openPR Logo
Press release

Investigation for Long-Term Investors in shares of Geron Corporation (NASDAQ: GERN) announced

04-20-2020 10:56 PM CET | Politics, Law & Society

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Geron Corporation (NASDAQ: GERN) shares.

An investigation on behalf of current long term investors in Geron Corporation (NASDAQ: GERN) shares.

An investigation was announced for current long-term investors in shares of Geron Corporation (NASDAQ: GERN) concerning potential breaches of fiduciary duties by certain directors and officers of Geron Corporation.

Investors who are current long term investors in Geron Corporation (NASDAQ: GERN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: GERN stocks follows a lawsuit filed against Geron Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: GERN stocks, concerns whether certain Geron directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District Court for the Northern District of California the plaintiff alleges that, the defendants: misled investors about the results of a clinical drug study of imetelstat called IMbark; and that as a result, defendants' statements about Geron's business, operations, and prospects were materially false and misleading and lacked a reasonable basis at all relevant times.

Those who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Long-Term Investors in shares of Geron Corporation (NASDAQ: GERN) announced here

News-ID: 2017670 • Views: 978

More Releases from Shareholders Foundation

Investigation for Investors in shares of Nutanix, Inc. (NASDAQ: NTNX) announced
An investigation is pending over potential securities laws violations by Nutanix, Inc. in connection with certain financial statements. Investors who purchased shares of Nutanix, Inc. (NASDAQ: NTNX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Nutanix, Inc. (NASDAQ: NTNX) concerning whether a series of statements
Baidu, Inc. (NASDAQ: BIDU) Long Term Investor Investigation of potential Wrongdo …
An investigation was announced for investors in shares of Baidu, Inc. (NASDAQ: BIDU) concerning potential breaches of fiduciary duties by certain directors of Baidu, Inc.. Investors who are current long term investors in Baidu, Inc. (NASDAQ: BIDU) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: BIDU stocks follows
Deadline on Nov. 24th coming up in Lawsuit for Investors in Garrett Motion Inc. …
A deadline is coming up on H November 24, 2020 in the lawsuit filed for certain investors of Garrett Motion Inc. (NYSE: GTX, OTC: GTXMQ) over alleged securities laws violations by Garrett Motion Inc. Investors who purchased shares of Garrett Motion Inc. (NYSE: GTX, OTC: GTXMQ) have certain options and there are strict and short deadlines running. Deadline: November 24, 2020. NYSE: GTX, OTC: GTXMQ stockholders should contact the Shareholders Foundation
Investigation announced for Long-Term Investors in shares of STAAR Surgical Comp …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of STAAR Surgical Company. Investors who are current long term investors in STAAR Surgical Company (NASDAQ: STAA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: STAA stocks follows a lawsuit filed against STAAR

All 5 Releases


More Releases for Geron

Stem Cells Industry Market has huge growth in industry 2020 : ViaCyte, Inc. , St …
Stem cell therapies possess significant potential in the treatment of various diseases and injuries. With several public and private organizations playing an active role in funding and encouraging stem cell-based research programs, the global stem cell therapy market is expected to grow at a significant pace during next decade. The stem cell therapy market comprises a range of stem cell-based products which are utilized for the treatment of various diseases
COVID-19 Impacts on Stem Cells Industry Market has huge growth in industry 2020 …
Market Definition: Stem cell therapies possess significant potential in the treatment of various diseases and injuries. With several public and private organizations playing an active role in funding and encouraging stem cell-based research programs, the global stem cell therapy market is expected to grow at a significant pace during next decade. The stem cell therapy market comprises a range of stem cell-based products which are utilized for the treatment of various
Deadline in Lawsuit for Investors in shares of Geron Corporation (NASDAQ: GERN) …
The Shareholders Foundation announced that a deadline is coming up on March 23, 2020 in the lawsuit filed for certain investors of Geron Corporation (NASDAQ: GERN) over alleged securities laws violations by Geron Corporation. Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and there are strict and short deadlines running. Deadline: March 23, 2020. NASDAQ: GERN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Stem Cell Therapy Market Insights, Segment Forecast With Osiris Therapeutics, B …
The stem cell therapy market report is a scrupulous investigation of current scenario of the global market, which covers several market dynamics. With the use of up to date and proven tools and techniques, complex market insights are organized in simpler version in this stem cell therapy report for the better understanding of end user. This global stem cell therapy market research report is organized by collecting market research data
Myelofibrosis Therapeutics Pipeline 2017 - Key Players Analysis CTI BioPharma, G …
The study analysed that the therapeutics pipeline comprises of approximately 29 drug candidates in different stages of development. Myelofibrosis is a rare disorder in which excessive scar tissue gets formed in the bone marrow that impairs its ability to produce red blood cells. However, it is believed by researchers that myelofibrosis occurs due to the presence of abnormal red blood stem cells in the bone marrow. The abnormal blood stem cells
Global Stem Cell Therapy Market Comprehensive 2018: BioTime, Osiris Therapeutics …
Stem cell therapy industry report contains explanation to what market definition, classifications, applications, engagements and market trends and also points at all the recent developments, product launches, joint ventures, merges and accusations by the several key players and brands that are driving the market whose company profiles are included in the report. Global stem cell therapy market 2018 research report is a proven source of information which offers a telescopic